Predicting who improves after phase II cardiac rehabilitation for reduced ejection fraction
Official title: Prédiction Des réponses du Patient Porteur d'Une Insuffisance Cardiaque à Fraction d'éjection altérée à Une Phase II de réadaptation Cardiaque
Run by Centre Hospitalier de Corbie · NCT07164911 · Data updated 2026-11-12
This project will test whether blood microRNA patterns together with non-invasive exercise measurements can predict which people with reduced ejection fraction heart failure will improve their peak oxygen uptake after a phase II cardiac rehab program.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 75 Years |
| Sex | All |
| Enrollment | 62 (estimated) |
| Sponsor | Centre Hospitalier de Corbie Government |
| Locations | 1 site (Corbie) |
| Status | Recruiting |
| Started | November 25, 2025 |
| Main results expected | October 31, 2027 |
| Study ends | November 30, 2027 |
| Registry record updated | December 16, 2025 |
| Trial ID | NCT07164911 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with HFrEF (LVEF <40%), NYHA class II or higher, clinically stable and on optimized medical therapy for at least 6 weeks, prescribed phase II cardiac rehabilitation, BMI 20–30 kg/m², sedentary or untrained, able to give informed consent and affiliated with the French national health insurance system.
✕Probably not a fit
Patients with contraindications to adapted physical activity, uncontrolled hypertension, significant secondary respiratory or cardiovascular disease, those outside the BMI or stability criteria, pregnant or breastfeeding individuals, or those unable to attend the center are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-center cohort of 62 patients with heart failure with reduced ejection fraction (LVEF <40%) who will complete a phase II exercise-based cardiac rehabilitation program. Researchers will measure peak oxygen uptake (VO2peak), cardiac hemodynamics, cerebral and muscle oxygenation during cardiopulmonary exercise testing, and circulating microRNA levels before and after the program. Participants will also perform a force–velocity test to guide individualized resistance training. The study links physiological exercise responses to molecular markers to identify predictors of improvement in ΔVO2peak.
Why it matters
Potential benefit: If successful, the findings could help personalize cardiac rehabilitation so clinicians can target the component(s) of oxygen delivery or utilization most likely to improve each patient’s exercise capacity.
How similar studies have gone: Exercise-based cardiac rehabilitation is known to improve VO2peak for many patients with HFrEF, but using circulating microRNAs to predict individual responses is a relatively novel approach that is not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Heart failure with reduced ejection fraction \< 40% * NYHA functional class ≥ II * Clinically stable for at least 6 weeks * On optimized medical therapy for at least 6 weeks * Prescription for phase II cardiac rehabilitation * BMI between 20-30 kg·m-² * Physical activity level: sedentary or physically active but untrained * Signed informed consent to participate in the study * Affiliation to the French national health insurance system Exclusion Criteria: * Contraindication to regular adapted physical activity * Uncontrolled arterial hypertension * Secondary respiratory disease such as emphysema or chronic obstructive pulmonary disease (COPD) * Secondary cardiovascular disease * Individuals under legal protection or deprived of liberty * Pregnant or breastfeeding women
Where it's running
-
Hospital center of Corbie
Corbie, France Recruiting
Study contacts
- Principal investigator: Francesco Orlando, MD — Centre Hospitalier de Corbie
- Study coordinator: Pierre-Marie Leprêtre, professor
- Email: pierre-marie.lepretre@univ-rouen.fr
- Phone: +33235148113
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Breathing muscle training plus dietary nitrate to improve exercise at simulated moderate altitude
This project tests whether breathing muscle training and beetroot-derived nitrate help healthy, active adults exercise better under simulated moderate-altitude (low-oxygen) conditions.
-
Outdoor resistance training for older adults
This trial tests a 6-week outdoor strength program using benches and a smartphone app to see if it’s safe, usable, and appealing for community-dwelling adults aged 65 and older.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Olive leaf extract plus endurance training to boost muscle performance in healthy adults
This study tests whether taking olive leaf extract while doing endurance training helps healthy adults improve their exercise performance more than training with a placebo.
-
Eccentric Hamstring Training vs Sprint-Specific Training for Hamstring Performance in Young Athletes
This study tests whether three hamstring training approaches (eccentric, sprint-based, and Romanian deadlift with Nordic hamstring) improve hamstring structure and sprint-related performance in healthy young athletes.
-
Guideline Adherence in HFrEF: See If Mirror Information Helps Doctors and Patients Follow GDMT
This study tests whether showing doctors, or both doctors and patients, mirror information about how well guideline-directed medical therapy is being used in heart failure with reduced ejection fraction.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.